Seeking Alpha

Cepheid (CPHD +1%) continues its upward trajectory today, having gained over 17% since last...

Cepheid (CPHD +1%) continues its upward trajectory today, having gained over 17% since last Thursday. Credit Suisse says it remains a top SMID cap pick given its best-in-class diagnostic testing platform and strong secular growth trends. Shares are Outperform rated with a $45 price target.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)